Filing Details
- Accession Number:
- 0001708138-20-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 18:21:57
- Reporting Period:
- 2020-05-20
- Accepted Time:
- 2020-05-22 18:21:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-21 | 683 | $577.37 | 307,849 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-21 | 100 | $578.34 | 307,749 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-03 | 564 | $0.00 | 144,333 | No | 5 | G | Indirect | by CLAT |
| Common Stock | Disposition | 2020-04-02 | 433 | $0.00 | 143,900 | No | 5 | G | Indirect | by CLAT |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Indirect | by CLAT |
| No | 5 | G | Indirect | by CLAT |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-05-20 | 3,264 | $0.00 | 3,264 | $30.63 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-20 | 77,309 | $0.00 | 77,309 | $30.63 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-20 | 77,309 | $0.00 | 77,309 | $30.63 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-20 | 77,309 | $0.00 | 77,309 | $30.63 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-20 | 77,309 | $0.00 | 77,309 | $30.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-14 | No | 4 | M | Direct | |
| 231,927 | 2020-12-14 | No | 4 | M | Direct | |
| 154,618 | 2020-12-14 | No | 4 | M | Direct | |
| 77,309 | 2020-12-14 | No | 4 | M | Direct | |
| 0 | 2020-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,207 | Indirect | By 401(k) Plan |
| Common Stock | 83,652 | Indirect | by Spouse as Trustee |
| Common Stock | 1,203 | Indirect | by trust for grandch |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 683 shares of Company stock on May 21, 2020 at prices ranging from $577.08 to $577.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price.
- By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Form two of two
Billionaire Hedge Funds
